In the field of cancer detection, technologies to analyze tumors using biomarkers circulating
in fluids such as blood have developed rapidly based on liquid biopsy. A proactive approach …

Cancer represents one of the conditions with the most causes of death worldwide. Common
methods for its diagnosis are based on tissue biopsies—the extraction of tissue from the …

Liquid biopsy, as a minimally invasive method of gleaning insight into the dynamics of
diseases through a patient fluid sample, has been growing in popularity for cancer …

Liquid biopsy for the analysis of circulating cancer biomarkers (CBs) is a major
advancement toward the early detection of cancer. In comparison to tissue biopsy …

Cancer today is one of the leading causes of mortality across the globe that can affect
humans in more than 100 diverse forms. Conventional diagnostic approaches, biopsy for …

Early cancer detection, its monitoring, and therapeutical prediction are highly valuable,
though extremely challenging targets in oncology. Significant progress has been made …

Microfluidic-based lab-on-a-chip technology is a multidisciplinary approach, which has
evolved rapidly in the past decade and remains a hot research topic as a promising …

Point-of-care diagnostic devices present a viable option for the rapid and sensitive detection
and analysis of cancer markers. With the growing number of cancer cases being diagnosed …

Early and timely diagnosis of cancer plays a decisive role in appropriate treatment and
improves clinical outcomes, improving public health. Significant advances in biosensor …

Gene mutation is associated with cancer and the dissemination of circulating biomarkers
through the blood represents a vital transitional step that exemplifies the shift from localized …